{"ABT": {"Ticker": "ABT", "Company": "Abbott Laboratories", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$110"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies"], "Price_Target": 110.0}, "ALL": {"Ticker": "ALL", "Company": "Allstate Corp", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$136 to $158"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Keefe Bruyette"], "Price_Target": 158.0}, "AIG": {"Ticker": "AIG", "Company": "American International Group", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$57 to $64"}, {"Date": "2022-10-10", "Rating": "Resumed", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$83"}, {"Date": "2022-10-10", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$58"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies", "BofA Securities", "Goldman"], "Price_Target": 68.33}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies"], "Price_Target": 62.0}, "BA": {"Ticker": "BA", "Company": "Boeing", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$98"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$180"}, {"Date": "2022-07-15", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$150 to $170"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BofA Securities", "Wolfe Research", "Credit Suisse"], "Price_Target": 149.33}, "BSX": {"Ticker": "BSX", "Company": "Boston Scientific", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$50"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies"], "Price_Target": 50.0}, "CBOE": {"Ticker": "CBOE", "Company": "Cboe Global Markets", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$130"}, {"Date": "2022-09-30", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$120 to $126"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$153"}, {"Date": "2022-07-19", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Overweight", "Target_Change": "$118 to $140"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Rosenblatt", "Citigroup", "Goldman", "Morgan Stanley"], "Price_Target": 137.25}, "SCHW": {"Ticker": "SCHW", "Company": "Charles Schwab Corporation", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$83"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$83"}, {"Date": "2022-08-31", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$81"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Barclays", "Citigroup", "Credit Suisse"], "Price_Target": 82.33}, "CME": {"Ticker": "CME", "Company": "CME Group", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$212 to $200"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$220"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Sell", "Target_Change": "$171"}, {"Date": "2022-08-15", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Rosenblatt", "Raymond James", "Deutsche Bank", "Citigroup"], "Price_Target": 197.0}, "DXCM": {"Ticker": "DXCM", "Company": "DexCom", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$125"}, {"Date": "2022-07-15", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$105"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies", "Bernstein"], "Price_Target": 115.0}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$110"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$115 to $106"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Canaccord Genuity"], "Price_Target": 108.0}, "FIS": {"Ticker": "FIS", "Company": "Fidelity National Information Services", "Sector": "Information Technology", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$125 to $90"}, {"Date": "2022-09-19", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$120 to $98"}, {"Date": "2022-09-08", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$96 to $88"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Wells Fargo", "Atlantic Equities", "Keefe Bruyette"], "Price_Target": 92.0}, "FISV": {"Ticker": "FISV", "Company": "Fiserv", "Sector": "Information Technology", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$130 to $105"}, {"Date": "2022-08-11", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": ""}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "Atlantic Equities"], "Price_Target": 105.0}, "FTV": {"Ticker": "FTV", "Company": "Fortive", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$68 to $73"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Morgan Stanley"], "Price_Target": 73.0}, "GD": {"Ticker": "GD", "Company": "General Dynamics", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$238"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$265"}, {"Date": "2022-08-30", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$275"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "Credit Suisse", "RBC Capital Mkts"], "Price_Target": 259.33}, "HWM": {"Ticker": "HWM", "Company": "Howmet Aerospace", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$31"}, {"Date": "2022-10-11", "Rating": "Resumed", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$44"}, {"Date": "2022-10-10", "Rating": "Initiated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$40"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "BofA Securities", "Truist"], "Price_Target": 38.33}, "HII": {"Ticker": "HII", "Company": "Huntington Ingalls Industries", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$245"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$315"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "Credit Suisse"], "Price_Target": 280.0}, "IBM": {"Ticker": "IBM", "Company": "IBM", "Sector": "Information Technology", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$163 to $158"}, {"Date": "2022-08-17", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$156 to $163"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse"], "Price_Target": 160.5}, "ICE": {"Ticker": "ICE", "Company": "Intercontinental Exchange", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$102"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$164"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Rosenblatt", "Citigroup"], "Price_Target": 133.0}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies"], "Price_Target": 210.0}, "KMB": {"Ticker": "KMB", "Company": "Kimberly-Clark", "Sector": "Consumer Staples", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Atlantic Equities", "Rating_Change": "Neutral to Overweight", "Target_Change": "$135"}, {"Date": "2022-09-14", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$130"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Atlantic Equities", "BofA Securities"], "Price_Target": 132.5}, "LHX": {"Ticker": "LHX", "Company": "L3Harris Technologies", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$267"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$238"}, {"Date": "2022-08-30", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$285"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "Wells Fargo", "Credit Suisse", "RBC Capital Mkts"], "Price_Target": 263.33}, "LMT": {"Ticker": "LMT", "Company": "Lockheed Martin", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$375"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$415"}, {"Date": "2022-08-30", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$460"}], "Score": -0.75, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wolfe Research", "Wells Fargo", "Credit Suisse", "RBC Capital Mkts"], "Price_Target": 416.67}, "MKTX": {"Ticker": "MKTX", "Company": "MarketAxess", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$285"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Sell", "Target_Change": "$231"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Rosenblatt", "Citigroup"], "Price_Target": 258.0}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$87"}, {"Date": "2022-08-24", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies", "Raymond James"], "Price_Target": 87.0}, "NDAQ": {"Ticker": "NDAQ", "Company": "Nasdaq", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$62"}, {"Date": "2022-10-06", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$70"}, {"Date": "2022-08-19", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$190 to $200"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$241"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Rosenblatt", "Atlantic Equities", "Citigroup", "JP Morgan"], "Price_Target": 143.25}, "NOC": {"Ticker": "NOC", "Company": "Northrop Grumman", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$560"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$565"}, {"Date": "2022-08-30", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$550"}, {"Date": "2022-07-29", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$488 to $529"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Robert W. Baird", "Wolfe Research", "Credit Suisse", "RBC Capital Mkts"], "Price_Target": 551.0}, "NCLH": {"Ticker": "NCLH", "Company": "Norwegian Cruise Line Holdings", "Sector": "Consumer Discretionary", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$18"}, {"Date": "2022-09-20", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$18 to $19"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS", "Truist"], "Price_Target": 18.5}, "PXD": {"Ticker": "PXD", "Company": "Pioneer Natural Resources", "Sector": "Energy", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$257 to $240"}, {"Date": "2022-09-20", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$290"}, {"Date": "2022-08-19", "Rating": "Downgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-07-20", "Rating": "Resumed", "Organization": "MKM Partners", "Rating_Change": "Buy", "Target_Change": "$264"}, {"Date": "2022-07-19", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$272 to $244"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Tudor, Pickering, Holt & Co.", "MKM Partners", "KeyBanc Capital Markets", "BofA Securities"], "Price_Target": 259.5}, "RJF": {"Ticker": "RJF", "Company": "Raymond James Financial", "Sector": "Financials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$117"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup"], "Price_Target": 117.0}, "RTX": {"Ticker": "RTX", "Company": "Raytheon Technologies", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$85"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wolfe Research", "Credit Suisse"], "Price_Target": 85.0}, "RMD": {"Ticker": "RMD", "Company": "ResMed", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2022-09-08", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-08-15", "Rating": "Downgrade", "Organization": "CLSA", "Rating_Change": "Buy to Outperform", "Target_Change": ""}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$246 to $252"}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": ""}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["CLSA", "Jefferies", "RBC Capital Mkts", "Citigroup", "JP Morgan"], "Price_Target": 252.0}, "SWK": {"Ticker": "SWK", "Company": "Stanley Black & Decker", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$110 to $82"}, {"Date": "2022-08-17", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$126 to $111"}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$105"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$130 to $110"}], "Score": -1.4, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Vertical Research", "Wolfe Research", "Morgan Stanley", "Deutsche Bank", "Wells Fargo"], "Price_Target": 102.0}, "SYK": {"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$270"}, {"Date": "2022-07-28", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-07-21", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$285 to $205"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Edward Jones", "Deutsche Bank"], "Price_Target": 237.5}, "TFX": {"Ticker": "TFX", "Company": "Teleflex", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$248"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies", "Wells Fargo"], "Price_Target": 229.0}, "COO": {"Ticker": "COO", "Company": "The Cooper Companies", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$400 to $295"}, {"Date": "2022-08-29", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies", "KeyBanc Capital Markets"], "Price_Target": 295.0}, "TDG": {"Ticker": "TDG", "Company": "TransDigm Group", "Sector": "Industrials", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$661"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$650"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wolfe Research", "Credit Suisse"], "Price_Target": 655.5}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-10-12", "Rating": [{"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$95"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies"], "Price_Target": 95.0}}